Tag: Kris Siemionow

MultiQure, a project developing an RNAi therapy targeting Huntington’s disease and other polyglutamine disorders, has been valued by Baker Tilly at USD 111.3 million....

Medicalgorithmics, a Warsaw Stock Exchange-listed developer of advanced cardiology technologies, is taking an important step toward expanding its therapeutic capabilities in cardiac surgery. The...

Medicalgorithmics S.A. closed the first quarter of 2026 with estimated consolidated sales revenue of PLN 10.2 million, representing a 51% year-on-year increase. The company...

Medicalgorithmics, a Warsaw Stock Exchange–listed developer of an advanced AI-driven ECG analysis platform, has signed a new agreement with its long-standing Canadian partner specializing...

Medicalgorithmics, the Polish medtech company listed on the Warsaw Stock Exchange, has completed the integration of its ECG analysis software (DRP) powered by proprietary...

Medicalgorithmics recorded a 38% year-on-year increase in revenue in the third quarter of this year, continuing its strong growth trajectory. The company generated nearly...

Warsaw-listed Medicalgorithmics continues its dynamic growth trajectory by signing a new agreement to provide AI-powered diagnostic software. The company’s latest partner is the largest...

Medicalgorithmics, a Warsaw Stock Exchange–listed leader in AI-powered cardiac diagnostic software, has reported estimated revenues of nearly PLN 7.2 million for the third quarter...

Listed on the Warsaw Stock Exchange, medtech company Medicalgorithmics continues to deliver on its growth strategy. In Q2 2025, the company secured seven major...

Polish medtech company Medicalgorithmics, listed on the Warsaw Stock Exchange, has signed a significant agreement with CardioScan, a global leader in cardiac diagnostics operating...